Protein Vaccine Demonstrates Less Reactogenicity than mRNA – A Real World Study
Matthew Rousculp, Ryan Ziemiecki, Anthony M. Marchese
doi: https://doi.org/10.1101/2023.05.31.23290594
Matthew Rousculp
1Novavax Inc., 21 Firstfield Rd., Gaithersburg, Maryland 20878, USA
Ryan Ziemiecki
2RTI Health Solutions, 3040 East Cornwallis Rd., Research Triangle Park, NC 27709, USA
Anthony M. Marchese
1Novavax Inc., 21 Firstfield Rd., Gaithersburg, Maryland 20878, USA
Data Availability
Requests for data will be considered.
Posted June 04, 2023.
Protein Vaccine Demonstrates Less Reactogenicity than mRNA – A Real World Study
Matthew Rousculp, Ryan Ziemiecki, Anthony M. Marchese
medRxiv 2023.05.31.23290594; doi: https://doi.org/10.1101/2023.05.31.23290594
Subject Area
Subject Areas
- Addiction Medicine (372)
- Allergy and Immunology (690)
- Anesthesia (184)
- Cardiovascular Medicine (2756)
- Dermatology (235)
- Emergency Medicine (414)
- Epidemiology (12404)
- Forensic Medicine (10)
- Gastroenterology (784)
- Genetic and Genomic Medicine (4266)
- Geriatric Medicine (396)
- Health Economics (700)
- Health Informatics (2760)
- Health Policy (1020)
- Hematology (370)
- HIV/AIDS (880)
- Medical Education (404)
- Medical Ethics (112)
- Nephrology (454)
- Neurology (4046)
- Nursing (216)
- Nutrition (600)
- Oncology (2132)
- Ophthalmology (606)
- Orthopedics (251)
- Otolaryngology (313)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (478)
- Pediatrics (1149)
- Primary Care Research (470)
- Public and Global Health (6659)
- Radiology and Imaging (1446)
- Respiratory Medicine (886)
- Rheumatology (421)
- Sports Medicine (353)
- Surgery (465)
- Toxicology (57)
- Transplantation (192)
- Urology (171)